Skip to main content

Organigram Global Inc.

OGI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001620737

No open-market purchases or sales by Organigram Global Inc. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $7.87M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Organigram Global Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of OGI: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders1232111−10
Shares19.7M1.61K25.5M+5.83M (+29.6%)
Value$15.9M$1.29K$16.5M+$595.6K (+3.7%)

2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held Organigram Global Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to OGI in Q1 2023
InstitutionSharesValue% of portfolio
ETF Managers Group, LLC7,353,933$4.71M0.15%
AXS Investments LLC1,377,288$881.5K0.29%
Jane Street Group, LLC77,003$49.0K0.00%
Psagot Value Holdings Ltd. / (Israel)37,774$24.0K0.01%
State of Wisconsin Investment Board16,570$10.5K0.00%
JustInvest LLC13,471$8.62K0.00%
Ameritas Advisory Services, LLC9,113$4.65K0.00%
Global Retirement Partners, LLC5,600$2.74K0.00%
EverSource Wealth Advisors, LLC1,350$8640.00%
BlackRock Inc.549$3510.00%
CWM, LLC500$00.00%

Sold out (21)

Institutions that held Organigram Global Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Not filed for Q1 2023 yet (2)

Institutions that held Organigram Global Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OGI in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
CoreCap Advisors, LLC1,010$808
Heritage Wealth Management, LLC600$480